National Institutes of Health-Chronic Prostatitis Symptom Index

Abstract

The National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) is a widely used, self-administered questionnaire designed to quantify the severity and impact of symptoms experienced by men suffering from Chronic Prostatitis (CP) or Chronic Pelvic Pain Syndrome (CPPS). The instrument assesses symptoms experienced by the patient over the preceding week. It consists of 13 items categorized into three distinct domains: pain, urinary function (micturition), and the resulting impact on the patient’s Quality of Life (QoL). A higher composite score indicates greater symptom burden and severity. The scale is known to be valid, reliable, and responsive in its original English format, although translated versions, such as the Dutch adaptation, may require further psychometric validation.

Keywords

NIH-CPSI, Chronic Prostatitis, Chronic Pelvic Pain, Urogenital symptoms, Symptom Index, Micturition, Quality of Life, Urological assessment.

Authors

Litwin MS (1999).

Purpose

The primary purpose of the NIH-CPSI is to provide a standardized, quantifiable measure of the primary symptoms associated with Chronic Pelvic Pain Syndrome (CPPS) and Chronic Prostatitis, specifically focusing on the severity and frequency of pain and voiding symptoms. Before the development of the NIH-CPSI, objective measures for evaluating treatment efficacy and disease progression in this patient population were often lacking, making this scale essential for clinical trials and routine urological practice.

The scale is designed to be highly responsive, allowing clinicians and researchers to track changes in patient status over time, particularly following therapeutic intervention. It captures the patient’s subjective experience, bridging the gap between clinical findings and the actual burden of the disease on daily living.

Construct

The NIH-CPSI measures the multidimensional construct of symptom severity and functional impairment related to chronic urogenital pain. This construct is broken down into three core factors, which align with the three domains of the questionnaire:

• Pain: This domain assesses the location, frequency, and severity of pain experienced in the perineal, testicular, or suprapubic regions.
• Urinary Symptoms (Micturition): This domain evaluates the frequency and severity of voiding difficulties, such as urgency, frequency, and dysuria.
• Quality of Life Impact: This domain measures the psychological and functional impact of the pain and urinary symptoms on the patient’s overall well-being, including emotional distress and limitations on daily activities.

Validity

The original English version of the NIH-CPSI has demonstrated strong psychometric properties, including robust construct and discriminant validity. Studies have confirmed that the scale effectively differentiates between men with CP/CPPS and healthy control subjects. Furthermore, the three domains show adequate factor loading consistent with the intended structure (Pain, Urinary Symptoms, QoL), supporting its conceptual framework.

While the scale has been translated into various languages, including Dutch, it is important to note that the source material indicates the Dutch translation has not yet undergone full psychometric validation to confirm its cross-cultural equivalence and continued validity in that specific population.

Reliability

High internal consistency and test-retest reliability have been established for the NIH-CPSI in English-speaking populations. The high reliability ensures that the measure provides consistent results when administered repeatedly under stable conditions, making it suitable for long-term monitoring of chronic conditions. The responsiveness of the scale—its ability to detect clinically meaningful changes—is also well-documented, reinforcing its utility in longitudinal clinical trials.

Factor Analysis

The scale was developed based on a clear conceptual framework, and subsequent confirmatory factor analysis (CFA) has generally supported the hypothesized three-factor structure (Pain, Urinary Symptoms, and Quality of Life Impact). The 13 items load appropriately onto these factors, confirming the scale’s ability to measure these distinct but related constructs. This factor structure is crucial for interpreting subscale scores, allowing clinicians to pinpoint the specific area of greatest patient burden.

Instrument

Test Type: Questionnaire (Self-report/Patient-Reported Outcome Measure (PROM))

Format: Written questionnaire consisting of 13 items, typically scored based on a recall period of the previous week. Scoring yields subscale scores for the three domains and a total composite score (ranging from 0 to 46).

Language Available: English (Validated), Dutch (Translated, validation pending), and numerous other languages.

Population Group: Men diagnosed with Chronic Prostatitis (Category III) or Chronic Pelvic Pain Syndrome (CPPS).

Age Group: Adults, Elderly.

Population Details: Individuals presenting with urogenital pain, voiding dysfunction, or symptoms related to inflammation or infection of the prostate or surrounding pelvic structures (Urine-incontinentie, Urogenitaal disorders).

Test Methodology: The patient responds to questions regarding symptom frequency and severity using Likert-type scales for quantification. The original PDF for the explanatory form can be downloaded here: Toelichtingsformulier (Explanation Form). The original PDF for the instrument itself can be downloaded here: Meetinstrument (Instrument).

Keywords

NIH-CPSI, Urological health, Pain assessment, Symptom severity index, Micturition symptoms, PROMs, Litwin MS, Urogenital disorders.

Authors

Author ORCID Identifier: Not provided in source.

Affiliation Email addresses: Not provided in source.

Correspondence Address: Not provided in source.

Permissions & Fee and Test Year

The scale was initially published in 1999 by Litwin MS et al. As a widely utilized public health measure developed under the auspices of the National Institutes of Health (NIH), the scale is generally considered to be in the public domain and is often used without explicit permission or fee for research and clinical purposes, although users should verify specific institutional policies.

Reference’s

The foundational research reference is:

• Litwin MS, McNaughton-Collins M, Fowler FJ Jr, Nickel JC, Curhan A, Chen R, Howards SS, Liberman J. The National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). J Urol. 1999 Dec;162(6):369-75.

Items of the National Institutes of Health-Chronic Prostatitis Symptom Index

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way.

The NIH-CPSI contains 13 items covering three domains (Pain, Urinary Symptoms, and Quality of Life Impact). Since the specific text of the original scale items was not provided in the source content, a generalized representation reflecting the structure based on the domains described is presented below:

1. Items related to the location, frequency, and severity of pain (4 items).
2. Items related to micturition/urinary function, such as frequency and urgency (2 items).
3. Items related to the impact of symptoms on daily life and general well-being (7 items).